companies / ceriatherapeutics-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 2,040,7842.0M | ○ |
|---|---|---|
| founded | null | |
| hq | BOULDER, Colorado | |
| industry | unknown | |
| stage | null |
Ceria Therapeutics develops RNA-interference therapies for acute inflammation in advanced wound, critical, and GI care, paired with in-house contract manufacturing for synthetic RNA and nanoparticles. It serves pharma developers who need both novel inflammation drugs and GMP-scale RNA/nanoparticle production. Capabilities include aerosolized formulation and analytics from research through GMP.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-01-01 | grant | 2,040,7842.0M | null | ○ |
Cloudflare, WordPress 6.9.4, Yoast SEO 27.6, jQuery Migrate 3.4.1, parallax.js, Cloudflare Bot Management, web-vitals, PHP, MySQL, jquery 3.7.1
| fact | status | src |
|---|---|---|
| Grant, $2.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |